Coreoside B
CAS No. 1580464-83-0
Coreoside B ( —— )
Catalog No. M29477 CAS No. 1580464-83-0
Coreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 302 | Get Quote |
|
10MG | 447 | Get Quote |
|
25MG | 714 | Get Quote |
|
50MG | 1017 | Get Quote |
|
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameCoreoside B
-
NoteResearch use only, not for human use.
-
Brief DescriptionCoreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.
-
DescriptionCoreoside B is isolated from coreoside and showed weak antimicrobial activity against S. aureus and B. anthracis.
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1580464-83-0
-
Formula Weight528.6
-
Molecular FormulaC25H36O12
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCC(CC/C=C/C#CC#C/C=C/CO)O[C@@H]([C@@H]([C@H]1O)O[C@@H]([C@@H]([C@H]2O)O)OC[C@@H]2O)O[C@H](CO)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Ridinilazole
Ridinilazole is a novel narrow-spectrum nonabsorbable antibiotic.
-
Q203
A novel potent anti-tuberculosis agent targeting cytochrome b subunit qcrB, inhibits M. tuberculosis H37Rv with MIC50 of of 2.7 nM.
-
Delpazolid
A novel oxazolidinone antibiotic that shows good antibacterial activity (MSSA MIC50=1 ug/mL).